Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 10, 2007

New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis
Nov 7, 2007

Sanofi Pasteur initiates phase II trial of cell culture-based seasonal influenza vaccine
Nov 7, 2007

Retrospective Analysis Finds that Initiation of Insulin Glargine in Patients with Type 2 Diabetes was Associated with a Lower Incidence Rate of Myocardial Infarction as Compared with NPH Insulin
Nov 6, 2007

Sanofi Pasteur presents positive results of tetravalent dengue candidate vaccine
Oct 31, 2007

Sanofi-aventis Announces Good Third Quarter Performance - Increase in 2007 full-year earnings growth guidance
Oct 24, 2007

Significant Survival Improvement with Taxotere®-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
Oct 24, 2007

New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR® (zolpidem tartrate extended-release) tablets CIV
Oct 19, 2007

Sanofi Pasteur receives FDA approval of meningococcal vaccine for children

Menactra® meningococcal conjugate vaccine approved for use in children 2 years through 10 years of age
Oct 19, 2007

Sixty Seconds That Can Change Your Life -- Simple test assesses osteoporosis risk and helps provide personal action plan for better bone health
Oct 15, 2007

Sanofi Pasteur and Institut Pasteur team up against malaria
Oct 2, 2007

New Prescription Allergy Treatment Xyzal® (levocetirizine dihydrochloride) Now Available For Fall Allergy Season
Oct 1, 2007

Taxotere® (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
Sep 27, 2007

FDA Approves New 300mg Loading Dose Tablet For Plavix® (Clopidogrel Bisulfate)
Sep 18, 2007

Sanofi Pasteur’s Investigational H5N1 Influenza Vaccine Achieves High Immune Response at Low Dosage

Clinical study demonstrates breakthrough dose-sparing formulation that increases stockpile capacities and expands potential production capacities to billions of doses in a pandemic situation
Sep 5, 2007

The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients with Atrial Fibrillation or Flutter With No Observed Pro-Arrhythmia
Aug 27, 2007

New 200 Mg Vial For Eloxatin® (Oxaliplatin Injection) Offers Greater Convenience And Efficiency Of Preparation
Aug 1, 2007

First half: solid results in a difficult context. Plavix® recovers its position in the US, full impact expected in H2
Jul 30, 2007

SoloSTAR®, the First Prefilled Disposable Insulin Pen for Lantus®, is Now Available in the United States
Jul 26, 2007

Sanofi pasteur President and CEO David J. Williams to retire; Wayne Pisano named President and CEO
Jun 29, 2007

Rimonabant Regulatory Update in the United States
Jun 27, 2007

Taxotere® (docetaxel) Granted FDA Priority Review for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck Prior to Chemoradiotherapy and Surgery
Jun 24, 2007

Apidra® Improved A1C In People With Type 2 Diabetes When Added to Basal Insulin And Oral Antidiabetic Treatments (BOT)
Jun 23, 2007

Results of Two Head-to-Head Studies Demonstrated Long-Acting Insulin Lantus® Lowered Free Fatty Acid Levels Equal to or Better
Jun 21, 2007

Basketball Hall of Fame Coach Chuck Daly Creates Game Plan to Manage the Symptoms of Benign Prostatic Hyperplasia (BPH)
Jun 20, 2007

Sanofi Pasteur Announces Completion of Construction of New U.S. Influenza Vaccine Manufacturing Facility

Sanofi pasteur Leads the Way in Influenza Vaccine Supply and Pandemic Preparedness

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.